ENCORE Research Group

Business Services · Florida, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

4800 Belfort Rd Ste 301, Jacksonville, F...

Phone Number

(904) 730-0101

Revenue

$8.1 Million

Industry

Business Services Research & Development

About ENCORE Research Group

Encore Research Group is a leading network of clinical research sites in Florida, conducting Phase IIV clinical trials in more than 50 therapeutic areas. The organization partners with pharmaceutical companies and medical device manufacturers to advance healthcare through high-quality, community-based clinical studies.Explore more
SIC Code 87,873NAICS Code 54,541Show more

ENCORE Research Group Org Chart

PhoneEmail
AE
United States flag for contact location.

Vice President, Central Recruiting With Encor...

PhoneEmail
EN
United States flag for contact location.

Vice President, Networking

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to ENCORE Research Group

Compare insights from companies similar to ENCORE Research Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

ENCORE Research Group

$8.1M
11-50
Private
-
1997
AE
Alyssa EchevarriaVice President, Central Recruiting With Encore Flourish
$5.7M
11-50
Private
<$5M
2014
KK
Kal KalenianPresident & CEO
<$5M
11-50
Private
-
-
CM
Candice MontrosClinical Manager
<$5M
11-50
Private
-
2017
KB
Kelly BryantVice President, Finance
Illustration of an envelope

ENCORE Research Group Tech Stack

A closer look at the technologies used by ENCORE Research Group

Top Business Services Companies

Frequently Asked Questions Regarding ENCORE Research Group

What is ENCORE Research Group's official website?
ENCORE Research Group's official website is www.encoredocs.com
What is ENCORE Research Group's Revenue?
ENCORE Research Group's revenue is $8.1 Million
What is ENCORE Research Group's SIC code?
ENCORE Research Group's SIC: 87,873
What is ENCORE Research Group's NAICS code?
ENCORE Research Group's NAICS: 54,541
How many employees does ENCORE Research Group have?
ENCORE Research Group has 11-50 employees
What industry does ENCORE Research Group belong to?
ENCORE Research Group is in the industry of: Business Services, Research & Development
What is ENCORE Research Group competition?
ENCORE Research Group top competitors include: Integrity Clinical Research Center, Rare Disease Research, Headlands Research Orlando
What companies has ENCORE Research Group acquired?
ENCORE Research Group has acquired the companies: Fleming Island Center for Clinical Research
What technology does ENCORE Research Group use?
Some of the popular technologies that ENCORE Research Group uses are: goo.gl, WooCommerce, WordPress.org, reCAPTCHA
How do I contact ENCORE Research Group?
ENCORE Research Group contact info: Phone number: (904) 730-0101 Website: www.encoredocs.com
What does ENCORE Research Group do?

Encore Research Group is a leading network of clinical research sites in Florida, conducting Phase IIV clinical trials in more than 50 therapeutic areas. The organization partners with pharmaceutical companies and medical device manufacturers to advance healthcare through high-quality, community-based clinical studies.... Read More

Is ENCORE Research Group a public company?
ENCORE Research Group is private company therefore does not currently have an official ticker symbol
See more information about ENCORE Research Group

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.